Natural Killer(NK) Cell Therapy Targeting CLL1 in Acute Myeloid Leukemia

NCT06027853 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

AML, Adult

Interventions

DRUG: CLL1 CAR-NK cell injection

Sponsor

Zhejiang University

Collaborators

[object Object]